SNY Jan 2025 35.000 put
- Reuters
US STOCKS-Futures rise ahead of data, speeches from Fed officials
U.S. stock index futures rose on Friday, as investors eagerly awaited comments from Federal Reserve officials to get more clarity on rate cuts, after economic data this week supported bets of monetary policy easing. Wall Street indexes were inching closer to record highs following a selloff last month, as a slew of economic data pointed to a cooling labor market, raising expectations that the Fed will cut borrowing costs more than once this year.
- Bloomberg
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot. Most Read from BloombergBiden Set to Impose Tariffs on China EVs, Strategic SectorsAckman Scolded Over DEI Views at Closed-Door Milken SessionApple Apologizes for iPad Pro Ad, Scraps Plan to Air It on TVMarjorie Taylor Greene Finally Got What She Deserved: Defeat‘Seriously Underwater’ Home Mortgages Tick Up Across the US
- Barrons.com
Novavax Stock Surges 120% on $1.4 Billion Deal With Sanofi
Novavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine could put it out of business, said it reached a $1.4 billion deal with French company Sanofi to commercialize its existing treatment and develop a new one. Shares spiked 120% in premarket trading to $10.02. Sanofi agreed to pay $500 million upfront and spend another $700 million when the company hits development, regulatory and launch milestones, Novavax said in a statement Friday.
